Skip to content

IAS: Remaining on 3TC despite resistance leads to better immunological and clinical outcomes

IAS: Treatment-related side-effects, sexual dysfunction and parental disapproval linked to sexual risk-taking in gay HIV-positive men

IAS: Growth hormone improves CD4 cell count in patients with a poor response to HAART

IAS: Have we prematurely discarded triple NRTI regimens?

IAS: Circumcision prevents three out of four female-to-male HIV infections

IAS: AZT-related anaemia is rare, but may be less prevalent with fixed-dose combinations, meta-analysis shows

IAS: Routine HIV testing acceptable to most pregnant women in Zimbabwe

IAS: UN HIV envoy delivers call to action to Rio conference

IAS: Single dose nevirapine for mother doesn't lead to worse CD4 response to HAART